{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Increased thrombotic and micro-vascular complications in severe COVID-19 patients, leading to COVID-19-associated coagulopathy (CAC)\",\"Impact\":\"Higher risk of mortality and severity of COVID-19\",\"Mitigation\":\"Implement anticoagulant therapy and closely monitor patients for signs of coagulopathy\",\"Technologies\":\"Anticoagulant medications, advanced monitoring systems\",\"People\":\"Severe COVID-19 patients, particularly those in ICU\",\"Owner\":\"Healthcare professionals, medical staff\"},{\"Description\":\"Invasion of the central nervous system by SARS-CoV-2, leading to neurological complications\",\"Impact\":\"Increased risk of neurological symptoms and complications, including loss of sight/smell/taste, headache, and stroke\",\"Mitigation\":\"Develop protocols for monitoring and managing neurological symptoms in COVID-19 patients, investigate treatments to protect the blood-brain barrier\",\"Technologies\":\"Neuroimaging, neurological monitoring devices, drug therapies targeting the blood-brain barrier\",\"People\":\"COVID-19 patients with neurological symptoms\",\"Owner\":\"Neurologists, healthcare professionals\"},{\"Description\":\"Active infection of the digestive system by SARS-CoV-2, leading to gastrointestinal symptoms\",\"Impact\":\"Increased prevalence of gastrointestinal symptoms such as diarrhea, vomiting, and related complications\",\"Mitigation\":\"Implement strategies to manage gastrointestinal symptoms in COVID-19 patients, develop treatments targeting digestive system infection\",\"Technologies\":\"Gastrointestinal diagnostic tools, antiviral therapies for the digestive system\",\"People\":\"COVID-19 patients with gastrointestinal symptoms\",\"Owner\":\"Gastroenterologists, healthcare professionals\"}]}"}}